Severe hepatotoxic adverse reaction in a healthy schoolgirl after treatment with flucloxacillin

Drug, Healthcare and Patient Safety

Volumn 1, Issue 1, 2009, Pages 17-19

  Törnhage, Carl Johan ^a   Brunlof G ^b   Wallerstedt, S M ^b  

^a CENTRAL HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adverse reaction; Children; Flucloxacillin; Hepatopathy

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; FLUCLOXACILLIN; GAMMA GLUTAMYLTRANSFERASE; PARACETAMOL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; CELLULITIS; CHILD; CLINICAL FEATURE; DIARRHEA; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER TOXICITY; SCHOOL CHILD; SIDE EFFECT; VOMITING;

EID: 77953401132     PISSN: None     EISSN: 11791365     Source Type: Journal    
DOI: 10.2147/dhps.s4316     Document Type: Article

References (12)

1. Impicciatore P, Choonara I, Clarkson A, Provasi O, Pandolfi ni C, Bonati M. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol. 2001;52:77-83.
2. Olsson R, Wiholm BE, Sand C, Zettergren L, Hultcrantz R, Myrhed M. Liver damage from fl ucloxacillin, cloxacillin and dicloxacillin. J Hepatol. 1992;15(1-2):154-161.
3. Lakehal F, Dansette PM, Becquemont L, et al. Indirect cytotoxicity of fl ucloxacillin toward human biliary epithelium via metabolite formation in hepatocytes. Chem Res Toxicol. 2001;14:694-701.
4. Andrews E, Daly AK. Flucloxacillin-induced liver injury. Toxicology. 2008;254(3):158-163.
5. Russmann S, Kaye JA, Jick SS, Jick H. Risk of cholestatic liver disease associated with fl ucloxacillin and fl ucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database. Br J Clin Pharmacol. 2005;60(1):76-82.
6. de Abajo FJ, Montero D, Madurga M, Garcia Rodriguez LA. Acute and clinically relevant drug-induced liver injury: a population based case-control study. Br J Clin Pharmacol. 2004;58:71-80.
7. Bjornsson E, Jerlstad P, Bergqvist A, Olsson R. Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden. Scand J Gastroenterol. 2005;40(19):1095-1101.
8. Bjornsson E, Kalaitzakis E, Olsson R. The impact of eosinophilia and hepatic necrosis on prognosis in patients with drug-induced liver injury. Aliment Pharmacol Ther. 2007;25:1411-1421.
9. Prescott LF, Critchley JA. Drug interactions affecting analgesic toxicity. Am J Med. 1983;75(5A):113-116.
10. Moling O, Cairon F, Rimenti G, Rizza F, Pristera R, Miani P. Severe hepatotoxicity after therapeutic doses of acetaminophen. Clin Ther. 2006;28(05):1755-1792.
11. Alvarez-Requejo A, Carvajal A, Begaud B, Moride Y, Vega T, Arias LH. Under-reporting of adverse drug reactions. Estimate based on a spontaneous reporting scheme and a sentinel system. Eur J Clin Pharmacol. 1998;54:483-488.
12. Backstrom M, Mjorndal T, Dahlqvist R. Under-reporting of serious adverse drug reactions in Sweden. Pharmacoepidemiol Drug Saf. 2004;13:483-487.